23andMe to Merge with Virgin Group’s VG Acquisition Corp. to Become Publicly-Traded Company Set to Revolutionize Personalized Healthcare and Therapeutic Development through Human Genetics
- Thursday, February 4, 2021, 7:17
- Business
- Add a comment
SUNNYVALE, Calif. and NEW YORK, Feb. 4, 2021 /PRNewswire/ — 23andMe, Inc., a leading consumer genetics and research company, and VG Acquisition Corp. (NYSE: VGAC), a special purpose acquisition company sponsored by Virgin Group, announced today that they have entered into a definitive…